Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients
Authors:
- Kumar SharmaKumar Sharma
- Guanshi ZhangGuanshi Zhang
- Jens HansenJHJens Hansen
- Petter BjornstadPBPetter Bjornstad
- Hak Joo LeeHLHak Joo Lee
- Rajasree MenonRMRajasree Menon
- Leila HejaziLHLeila Hejazi
- Jian-Jun LiuJLJian-Jun Liu
- Anthony FranzoneAFAnthony Franzone
- Helen C. LookerHLHelen C. Looker
- Byeong Yeob ChoiBCByeong Yeob Choi
- Roman FernandezRFRoman Fernandez
Top Cited Papers
Open Access
- 16 October 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (20)
Abstract
Diabetic kidney disease (DKD) can lead to end-stage kidney disease (ESKD) and mortality; however, few mechanistic biomarkers are available for high-risk patients, especially those without macroalbuminuria. Urine from participants with diabetes from the Chronic Renal Insufficiency Cohort (CRIC) study, the Singapore Study of Macro-angiopathy and Micro-vascular Reactivity in Type 2 Diabetes (SMART2D), and the American Indian Study determined whether urine adenine/creatinine ratio (UAdCR) could be a mechanistic biomarker for ESKD. ESKD and mortality were associated with the highest UAdCR tertile in the CRIC study and SMART2D. ESKD was associated with the highest UAdCR tertile in patients without macroalbuminuria in the CRIC study, SMART2D, and the American Indian study. Empagliflozin lowered UAdCR in nonmacroalbuminuric participants. Spatial metabolomics localized adenine to kidney pathology, and single-cell transcriptomics identified ribonucleoprotein biogenesis as a top pathway in proximal tubules of patients without macroalbuminuria, implicating mTOR. Adenine stimulated matrix in tubular cells via mTOR and stimulated mTOR in mouse kidneys. A specific inhibitor of adenine production was found to reduce kidney hypertrophy and kidney injury in diabetic mice. We propose that endogenous adenine may be a causative factor in DKD.Keywords
Funding Information
- NIH (UH3DK114920)
This publication has 46 references indexed in Scilit:
- Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney DiseaseJournal of the American Society of Nephrology, 2013
- Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 DiabetesDiabetes, 2013
- Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 DiabetesJournal of the American Society of Nephrology, 2013
- Albuminuria and Estimated Glomerular Filtration Rate as Predictors of Diabetic End-Stage Renal Disease and DeathClinical Journal of the American Society of Nephrology, 2011
- Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injuryNature Medicine, 2010
- Chronic Kidney Disease and Cognitive Function in Older Adults: Findings from the Chronic Renal Insufficiency Cohort Cognitive StudyJournal of the American Geriatrics Society, 2010
- Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel StrategyPLOS ONE, 2009
- Regression of Microalbuminuria in Type 1 DiabetesNew England Journal of Medicine, 2003
- The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?Diabetes, 2000
- The kidney in diabetesThe American Journal of Medicine, 1981